257 results on '"Philosophe B"'
Search Results
2. The Maryland Aggregate Pathology Index: A Deceased Donor Kidney Biopsy Scoring System for Predicting Graft Failure
3. Shorter Waitlist Time for HCV+ Renal Allografts Improves Long-Term Graft Survival Without Associated Progression of Clinical Liver Disease.: Abstract# 2874
4. Finding the “Diamond in the Rough” Kidneys Amongst Deceased Donors With a High Terminal Creatinine (hiCr).: Abstract# 2870
5. Early Withdrawal of Calcineurin Inhibitors and Rescue Immunosuppression with Sirolimus-Based Therapy in Renal Transplant Recipients with Moderate to Severe Renal Dysfunction
6. Estimated Benefits of Transplantation of Kidneys from Donors at Increased Risk for HIV or Hepatitis C Infection
7. MINIMIZING PORT SITES FOR TOTAL LAPAROSCOPIC LEFT LATERAL HEPATIC SEGMENTECTOMY USING “LESS” APPROACH: 644
8. End-stage renal disease and African American race are independent predictors of mild liver fibrosis in patients with chronic hepatitis C infection
9. Donor Satisfaction and Safety Support Preferred Approach of SinglePort Donor Nephrectomy.: Abstract# 1632: Poster Board #-Session: P194-IV
10. Liver Allografts Suppress Cellular and Humoral Responses towards Co-Transplanted Heart Allografts.: Abstract# 1206 Poster Board #-Session: P73-III
11. Proteinuria and Acute Cellular Rejection Did Not Impact Graft Survival in Patients Converted to Sirolimus in Intermediate Maryland Aggregate Pathology Index (iMAPI).: Abstract# 937 Poster Board #-Session: P102-II
12. Multi-Organ and Complex Full Facial Segment Procurement from a Brain Dead Donor.: Abstract# 832 Poster Board #-Session: P300-I
13. Very Rapid Steroid Withdrawal Is Not Associated with Increased Early Rejection in Hepatitis C Liver Transplant Recipients.: Abstract# 711: Poster Board #-Session: P179-I
14. Knowing a Good Thing When You See It - The Utility of HCV+ Deceased Donor Kidney Transplantation.: Abstract# 497
15. Sirolimus Conversion Prevents Progression of Fibrosis of Marginal Kidneys with Intermediate Maryland Aggregate Pathology Index (iMAPI) Scores.: Abstract# 121
16. 3:45 PM Abstract No. 276 Can pretransplant TACE improve overall posttransplant survival for patients with hepatocellular carcinoma?
17. Histological findings in “incidental” intraoperative pancreas allograft biopsies
18. Peripheral administration of thymoglobulin for induction therapy in pancreas transplantation
19. Shorter Waitlist Time for HCV+ Renal Allografts Improves Long-Term Graft Survival Without Associated Progression of Clinical Liver Disease.
20. Finding the “Diamond in the Rough” Kidneys Amongst Deceased Donors With a High Terminal Creatinine (hiCr).
21. Efficiency of the LigaSure Vessel Sealing System for Recipient Hepatectomy in Liver Transplantation
22. Multi-Organ and Complex Full Facial Segment Procurement from a Brain Dead Donor
23. Improved Efficiency of LigaSure Vessel Sealing System for Recipient Hepatectomy in Liver Transplantation
24. CAMPATH INDUCTION DOES NOT PREDISPOSE TO CYTOMEGALOVIRUS DISEASE
25. SAFE AND ROUTINE APPLICATION OF LAPAROENDOSCOPIC SINGLE SITE (LESS) DONOR NEPHRECTOMIES: EXPERIENCE WITH 60 CASES
26. LIVING KIDNEY DONOR RELATIONSHIPS IN CAUCASIAN AND AFRICAN-AMERICAN POPULATIONS AND IMPLICATIONS FOR TARGETED DONOR EDUCATION PROGRAMS
27. THE MARYLAND AGGREGATE PATHOLOGY INDEX (MAPI) IS SUPERIOR TO THE KIDNEY DONOR RISK INDEX (KDRI) AS A PREDICTOR OF GRAFT OUTCOME.
28. 12-MONTH, SINGLE-CENTER EVALUATION OF GI COMPLICATIONS IN RENAL TRANSPLANT RECIPIENTS INITIATED ON MYCOPHENOLIC ACID (MPA) THERAPY
29. THE INFLUENCE OF DONOR TYPE ON URETERAL COMPLICATIONS AFTER KIDNEY TRANSPLANTATION
30. A BANFF CV2 LESION IN A PRE-IMPLANTATION BIOPSY IS THE BEST PREDICTOR OF DELAYED GRAFT FUNCTION FOLLOWING RENAL TRANSPLANTATION.
31. VALIDATION OF THE MARYLAND AGGREGATE PATHOLOGY INDEX (MAPI) ON PRE-IMPLANTATION BIOPSIES (PIB) AS A PREDICTOR OF GRAFT OUTCOME AT TWO INDEPENDENT TRANSPLANT CENTERS.
32. Pancreas Retransplantation at a Single Institution over a 20 Year Period
33. QS455. Volume-Outcome Relationship in the Procurement of Transplantable Deceased Donor Organs
34. PANCREAS TRANSPLANT ALONE (PTA) AS AN INDEPENDENT RISK FACTOR FOR THE DEVELOPMENT OF RENAL FAILURE
35. C4D+ ANTIBODY MEDIATED REJECTION AND CAMPATH INDUCTION ARE RISK FACTORS FOR GRAFT LOSS FOLLOWING PANCREAS TRANSPLANTATION
36. MACHINE PULSATILE PERFUSION AND ITS PREDICTIVE VALUE FOR DELAYED GRAFT FUNCTION IN CADAVERIC RENAL TRANSPLANTS (CRT)
37. DONATION AFTER CARDIAC DEATH LIVER TRANSPLANTATION DOES NOT INFLUENCE EARLY HEPATITIS C RECURRENCE OR OUTCOMES
38. PREDICTING GRAFT OUTCOME WITH EVALUATION OF PRE-TRANSPLANT KIDNEY BIOPSY USING A CUMULATIVE PATHOLOGY SCORE
39. SUCCESSFUL ALEMTUZUMAB INDUCTION AND STEROID WITHDRAWAL IN AFRICAN AMERICAN AND CAUCASIAN RECIPIENTS OF RENAL TRANSPLANTS
40. PREDICTORS OF POOR EARLY GRAFT FUNCTION FOLLOWING LAPAROSCOPIC DONOR NEPHRECTOMY (LDN)
41. HCV+ RENAL TRANSPLANT PATIENTS DO NOT PROGRESS TO LIVER CIRRHOSIS FOLLOWING T-CELL DEPLETION
42. VOLUME-OUTCOME RELATIONSHIP IN THE PROCUREMENT OF TRANSPLANTABLE ORGANS
43. 195
44. BASILIXIMAB INDUCTION ALLOWS THE DELAY OF TACROLIMUS FOLLOWING LIVER TRANSPLANTATION IN PATIENTS WITH RENAL INSUFFICIENCY
45. FAVORABLE LONG TERM RESULTS WITH THYMOGLOBULIN (RATG) INDUCTION IN PANCREAS TRANSPLANTATION
46. RAPID STEROID ELIMINATION AFTER LIFE-DONOR RENAL TRANSPLANTATION: BASILIXIMAB INDUCTION (MMF,TACROLIMUS) VERSUS STANDARD IMMUNOSUPPRESSION (STEROIDS,MMF AND TACROLIMUS)
47. Study 1: one-year results of the first prospective, randomized, multicenter kidney transplant study comparing tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil combination therapy
48. A Comparison of Recipient Renal Outcomes With Laparoscopic Versus Open Live Donor Nephrectomy
49. COMORBID CONDITIONS AS PREOPERATIVE PREDICTORS FOR HIGH COST OF LIVE DONOR KIDNEY TRANSPLANTATION
50. RESULTS OF 295 LAPAROSCOPIC LIVE DONOR KIDNEY TRANSPLANTS AT ONE INSTITUTION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.